Inovio Pharmaceuticals
INO
HK$11.62
Share price
0.68%
Change (1 day)
-86.32%
Change (1 year)
Categories
Revenue for Inovio Pharmaceuticals (INO)
Revenue in 2025 (TTM): HK$2.2 Million
According to Inovio Pharmaceuticals's latest financial reports the company's current revenue (TTM 
) is HK$2.22 Million. In 2024 the company made a revenue of HK$1.69 Million a decrease over the revenue in the year 2023 that were of HK$6.49 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Inovio Pharmaceuticals from 1999 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | HK$2.2 M | 30.34% |
| 2024 | HK$1.69 M | -73.98% |
| 2023 | HK$6.49 M | -91.9% |
| 2022 | HK$80.18 M | 479.4% |
| 2021 | HK$13.83 M | -75.91% |
| 2020 | HK$57.45 M | 79.41% |
| 2019 | HK$32.02 M | -86.58% |
| 2018 | HK$0.23 B | -27.64% |
| 2017 | HK$0.32 B | 20.27% |
| 2016 | HK$0.27 B | -12.78% |
| 2015 | HK$0.31 B | 287.71% |
| 2014 | HK$81.1 M | -22.33% |
| 2013 | HK$0.10 B | 227.12% |
| 2012 | HK$31.92 M | -58.04% |
| 2011 | HK$76.07 M | 59.1% |
| 2010 | HK$47.81 M | -32.38% |
| 2009 | HK$70.71 M | 336.26% |
| 2008 | HK$16.2 M | -56.76% |
| 2007 | HK$37.48 M | 38.97% |
| 2006 | HK$26.97 M | -36.37% |
| 2005 | HK$42.38 M | 367.37% |
| 2004 | HK$9.06 M | 1353.03% |
| 2003 | HK$0.62 M | -57.77% |
| 2002 | HK$1.47 M | |
| 2000 | HK$43.41 M | -36.5% |
| 1999 | HK$68.36 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | HK$490.28 B | 22,063,912.94% | 🇺🇸 USA |
 Johnson & Johnson JNJ | HK$701.17 B | 31,554,585.82% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | HK$4.27 B | 192,485.99% | 🇺🇸 USA |
 Novartis NVS | HK$417.75 B | 18,799,683.82% | 🇨🇭 Switzerland |
 Merck MRK | HK$501.73 B | 22,579,280.36% | 🇺🇸 USA |
 GlaxoSmithKline GSK | HK$318.57 B | 14,336,433.75% | 🇬🇧 UK |
 Gilead Sciences GILD | HK$225.53 B | 10,149,706.25% | 🇺🇸 USA |
 Cleveland BioLabs
CBLI | HK$4.95 M | 123.19% | 🇺🇸 USA |